EUVIMEDEUVIMED entdecken
Open Access

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma

Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, Fabio Scirocchi, Delia Scocozza, Barbara Peixoto, Angelica Pace, Luca D'Angelo, James K C Liu, Arnold B Etame, Aurelia Rughetti, Marianna Nuti und 5 weitere

Immunity · 2024-05 · 57 (5) · 1105-1123.e8

DOI: 10.1016/j.immuni.2024.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024-05. Verfasst von Alessandra De Leo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Ph…. Hauptthemen laut MEDLINE: Glioblastoma, Histones, Macrophages, Glucose. Die Arbeit wurde bisher 356-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppressive macrophages restrict anti-cancer immunity in glioblastoma (GBM). Here, we studied the contribution of microglia (MGs) and monocyte-derived macrophages (MDMs) to immunosuppression and mechanisms underlying their regulatory function. MDMs outnumbered MGs at late tumor stages and suppressed T cell activity. Molecular and functional analysis identified a population of glycolytic MDM expressing GLUT1 with potent immunosuppressive activity. GBM-derived factors promoted high glycolysis, lactate, and interleukin-10 (IL-10) production in MDMs. Inhibition of glycolysis or lactate production in MDMs impaired IL-10 expression and T cell suppression. Mechanistically, intracellular lactate-driven histone lactylation promoted IL-10 expression, which was required to suppress T cell activity. GLUT1 expression on MDMs was induced downstream of tumor-derived factors that activated the PERK-ATF4 axis. PERK deletion in MDM abrogated histone lactylation, led to the accumulation of intratumoral T cells and tumor growth delay, and, in combination with immunotherapy, blocked GBM progression. Thus, PERK-driven glucose metabolism promotes MDM immunosuppressive activity via histone lactylation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHistonesMacrophagesGlucoseAnimalsMiceHumansCell Line, TumorBrain NeoplasmsGlucose Transporter Type 1Interleukin-10GlycolysisMicrogliaMice, Inbred C57BLT-LymphocytesImmune Tolerance

Stichwörter der Autor:innen

ER stressPERKbrain cancerglioblastomaglycolysishistone lactylationimmunosuppressionmetabolismmyeloid cellstumor-associated macrophages

Substanzen

HistonesGlucoseGlucose Transporter Type 1Interleukin-10

Autor:innen und Institutionen

  • Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA; Department of Experimental Medicine "Sapienza" Un…
  • Department of Biostatistics and Bioinformatic, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Department of Experimental Medicine "Sapienza" University of Rome, Rome, Italy.
  • Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Department of Experimental Medicine "Sapienza" University of Rome, Rome, Italy.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • American Cancer Society
  • Ben and Catherine Ivy Foundation
  • National Cancer Institute
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

De Leo, A., Ugolini, A., Yu, X., Scirocchi, F., Scocozza, D., Peixoto, B., Pace, A., D'Angelo, L., Liu, J. K. C., Etame, A. B., Rughetti, A., Nuti, M., Santoro, A., Vogelbaum, M. A., Conejo-Garcia, J. R., Rodriguez, P. C., & Veglia, F. (2024). Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity, 57(5), 1105-1123.e8. https://doi.org/10.1016/j.immuni.2024.04.006

Vancouver

De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity. 2024;57(5):1105-1123.e8. doi:10.1016/j.immuni.2024.04.006

BibTeX
@article{DeLeo2024,
  author = {De Leo, Alessandra and Ugolini, Alessio and Yu, Xiaoqing and Scirocchi, Fabio and Scocozza, Delia and Peixoto, Barbara and Pace, Angelica and D'Angelo, Luca and Liu, James K C and Etame, Arnold B and Rughetti, Aurelia and Nuti, Marianna and Santoro, Antonio and Vogelbaum, Michael A and Conejo-Garcia, Jose R and Rodriguez, Paulo C and Veglia, Filippo},
  title = {Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma},
  journal = {Immunity},
  year = {2024},
  volume = {57},
  number = {5},
  pages = {1105--1123.e8},
  doi = {10.1016/j.immuni.2024.04.006}
}
Kostenlos starten →